Speak with our HG Experts
To contact the HER Foundation for interviews, please email media@hyperemesis.org.
HG women in your area
To find women around the world willing to share their stories to help raise awareness of HG, please email media@hyperemesis.org.
Media Relations Contacts
Please direct media inquiries to media@hyperemesis.org.
Our HG Experts
Dr. Marlena Fejzo, a Harvard-trained women's health researcher, specializing in genetics, an affiliated with the University of Southern California. Dr. Fejzo is credited with discovering the cause of HG and is the world's leading research scientist on HG and a HER Foundation Board member and Research Advisor. Dr. Fejzo endured HG during her pregnancies. Email her at research at hyperemesis.org.
Dr. Aimee Brecht-Doscher is an OBGYN in the Los Angeles area who has personally been affected by HG. She is a HER Foundation Board member and the Medical Advisor for the Foundation. Email her at aimee at hyperemesis.org.
Kimber MacGibbon is a registered nurse (RN) and has helped many thousands of families facing HG across the globe since 2000. She has an extensive understanding of HG from a medical, advocacy, and personal perspective. Kimber is also co-founder of the HER Foundation. She and Dr. Fejzo have co-authored over three dozen publications on HG in collaboration with universities, including USC and UCLA. Kimber had HG in both of her pregnancies and is located in Portland, Oregon. Email her at kimber at hyperemesis.org.
Press Releases
- GDF15 linked to maternal risk of nausea and vomiting during pregnancy - December 2023
- Amy Schumer joins the Board of Directors of the Hyperemesis Education and Research
(HER) Foundation - May 2022 - Researchers Identify Gene Mutation Linked to Pregnancy Sickness - March 2022
- HER Foundation HG Awareness Day - Raise Your Voice - May 2020
- HG Awareness Day 2019 – May 2019
- HER Foundation Helps UCLA and 23 & Me with Genetic Studies – March 2018
- HER Foundation Responds to Duchess’ Third HG Pregnancy – September 2017
- HER Foundation donates $46,000 to UCLA geneticist for research into Hyperemesis Gravidarum – September 2012
- UCLA: Extreme morning sickness could lead to lifelong emotional, behavioral disorders in kids – August 2011
- Moms and Experts Meet On Capitol Hill, Give Voice To Overlooked Pregnancy Disease – September 2005
- HER Foundation Releases Survey Results On Hyperemesis Gravidarum – May 2005
- Untreated Hyperemesis Predisposes Babies to Diseases – December 2003
- Devastating illness for moms’-to-be in need of research to save lives – June 2003
Statistics and Fact Sheets
- HER Foundation Fact Sheet
- Advocacy Priorities
- Research Presentation Poster: SMFM 2019 Genetics Poster
- Research Presentation Poster:
Symptomatology and Outcomes of Women with HG as Reported in a Large Registry - Research Presentation Poster:
Familial Aggregation of HG - Research Presentation Poster:
Voluntary Termination in a Large Cohort of Women with Hyperemesis Gravidarum - Research Presentation Poster:
Secular Trends in the Treatment of Hyperemesis Gravidarum - Research Presentation Poster:
Extreme Weight Loss and Extended Duration of Symptoms Common in Hyperemesis Gravidarum
Impact of COVID-19 and women’s health: challenges and lessons
On March 10, 2021, our 1 MOM is 2 Many partner, African Health Now, hosted a webinar: Impact of COVID-19 and Women’s Health Challenges and Lessons. The HER Foundation joined African Health Now, Every Mother Counts, and other experts to discuss the impact of COVID-19 on women’s access to healthcare services, including maternal and reproductive healthcare.
Chair of Board of Directors Job Posting 3/1/21
About HER HER Foundation is a 501c3 nonprofit organization dedicated to providing support, groundbreaking research, advocacy, and education on hyperemesis gravidarum (HG), a potentially life-threatening pregnancy disease that causes weight…
New Research Published: HELP Score
The HER Foundation publishes a new study demonstrating the effectiveness of the HyperEmesis Level Prediction (HELP) Score in identifying pregnant women with severe symptoms of NVP.
